Autres langues CKD Bio Corp.

Actions

A063160

KR7063160006

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 20/05/2024			Varia. 5j.	Varia. 1 janv.
23 900 ^KRW	-0,42%		-2,05%	+0,21%

2023	CKD Bio Corp. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI
2023	CKD Bio Corp. déclare ses résultats pour le premier trimestre clos le 31 mars 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea	27/02
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index	18/09/23
CKD Bio Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
CKD Bio Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
CKD Bio Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
CKD Bio Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	17/03/22
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Exclusive: South Korea's GL Rapha to ship out 10 million Sputnik Light COVID-19 shots this month	14/09/21
Boryung Pharmaceutical : S.Korea's GL Rapha to ship out 10 mln Sputnik Light COVID-19 shots this month	14/09/21
CKD Bio Corp.(KOSE:A063160) added to S&P Global BMI Index	21/09/20
Chong Kun Dang Holdings Corp. completed the acquisition of additional 35.67% stake in Ckd Bio Corporation for KRW 61.6 billion.	12/07/16
Chong Kun Dang Holdings Corp. made an offer to acquire an additional 35.67% stake in Ckd Bio Corporation for KRW 55.9 billion.	19/05/16
Korea Securities Finance Corporation acquired 4.11% stake in Ckd Bio Corporation.	09/01/15
Ckd Bio Corporation Announces Earnings Results for the Full Year Ended December 31, 2012	20/05/13

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.

PROFITEZ-EN MAINTENANT